BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 177 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,198,000 | -23.4% | 25,641 | -41.9% | 4.32% | -35.5% |
| Q3 2020 | $2,868,000 | -68.1% | 44,112 | -64.1% | 6.69% | -34.1% |
| Q2 2020 | $8,983,000 | -1.5% | 122,865 | -54.1% | 10.16% | +21.9% |
| Q1 2020 | $9,116,000 | -37.5% | 267,868 | -0.0% | 8.33% | -28.4% |
| Q4 2019 | $14,584,000 | +30.6% | 267,900 | +0.1% | 11.64% | -21.6% |
| Q3 2019 | $11,170,000 | – | 267,728 | – | 14.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |